Rheumatology
Adult-Onset Still's Disease
Yamaguchi criteria — quotidian fever + salmon rash + arthritis + ferritin ↑↑ — exclude infection / malignancy first.
Source: EULAR 2024
Step 1 of ~3
info
Yamaguchi Criteria
Diagnosis (≥5 with ≥2 major):
Major: fever ≥39°C >1 week (quotidian — daily spikes); arthralgia / arthritis ≥2 weeks; salmon-pink evanescent rash; leukocytosis ≥10 with ≥80% neutrophils.
Minor: sore throat; lymphadenopathy / hepatosplenomegaly; abnormal LFTs; negative RF + ANA.
Exclude: infection (especially viral, TB, endocarditis), malignancy (especially lymphoma, leukaemia), other autoimmune, Behçet's, drug reaction.
Ferritin often massively raised (>1000–10,000) — glycosylated ferritin <20% supportive but not diagnostic.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Paracetamol (Paediatric) · Analgesic / Antipyretic — First-Line Pain and Fever in Children
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Promethazine hydrochloride · First-generation H1-antihistamine (phenothiazine)
- Tolbutamide · First-generation sulfonylurea (short-acting)
- Calcitonin (salmon) · Calcitonin analogue
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only. Always apply local guidelines and clinical judgement.